A Negative Trial of Sodium Valproate in Cluster Headache: Methodological Issues

We report the result of a double-blind placebo controlled study of sodium valproate (SV) (1000-2000 mg/day) in the prophylaxis of cluster headache CH. Episodic and chronic CH were defined according to the International Headache Society classification. Ninety- six patients were included, 50 in the SV...

Full description

Saved in:
Bibliographic Details
Published in:Cephalalgia 2002-04, Vol.22 (3), p.205-208
Main Authors: Amrani, M El, Massiou, H, Bousser, MG
Format: Article
Language:English
Subjects:
Adult
Chi-Square Distribution
Cluster headache
Cluster Headache - drug therapy
Double-Blind Method
Female
Humans
Male
methodological issues
Middle Aged
Placebo Effect
prophylactic treatment
sodium valproate
Statistics, Nonparametric
Valproic Acid - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We report the result of a double-blind placebo controlled study of sodium valproate (SV) (1000-2000 mg/day) in the prophylaxis of cluster headache CH. Episodic and chronic CH were defined according to the International Headache Society classification. Ninety- six patients were included, 50 in the SV group and 46 in the placebo group. After a 7-day run-in period, patients were treated for 2 weeks. The primary efficacy criterion was the percentage of patients successfully improved, i.e having an at least 50% reduction in the average number of attacks per week between the run-in period and the last week of treatment. Whatever the type of CH, there was no difference between the two groups: 50% of subjects in the SV group and 62% in the placebo group were successfully improved (P = 0.23). This high success rate observed in the placebo group, which is likely to be due to the spontaneous remission of the episode, does not allow us to draw any valid conclusion with regard to the true efficacy of SV in the prophylaxis of CH.
ISSN:0333-1024
1468-2982
DOI:10.1046/j.1468-2982.2002.00349.x